Brian Wright says the House vs. Burwell ruling is unlikely to have much practical effect on the companies he tracks for at least a year. (TS/John Kroetch)

A securities analyst says the new federal court ruling against a Patient Protection and Affordable Care Act (PPACA) subsidy program is probably more of a buying opportunity for investors than a calamity for insurers.

In a new commentary, Sterne Agee CRT Analyst Brian Wright, who follows health insurers and hospital companies, looks at the possible effects of the District of Columbia decision on the PPACA cost-sharing reduction subsidy program.